[{"from": "human", "value": "Provide a brief overview of this molecule. [C][N@@+1][Branch2][Ring2][=Branch2][C][C][C][=C][C][=Branch2][Ring1][#C][=C][Branch2][Ring1][=Branch2][C][=C][Ring1][=Branch1][C@H1][Ring1][#Branch2][C][C][=C][C][=Branch1][#Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][O][C][O][C][O][C][C][C][C][=Branch1][C][=O][O][C][C][C][C][C][O][C][=Branch1][C][=O][C][C][N@+1][Branch2][Ring2][=Branch2][C][C][C][=C][C][=Branch2][Ring1][#C][=C][Branch2][Ring1][=Branch2][C][=C][Ring1][=Branch1][C@H1][Ring1][#Branch2][C][C][=C][C][=Branch1][#Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][O][C][O][C][O][C][C]"}, {"from": "gpt", "value": "The molecule is a non-depolarising neuromuscular blocking agent of the benzylisoquinolinium class, available in its salt form, cisatracurium besylate. Cisatracurium has an intermediate duration of action and is one of the most commonly used neuromuscular blocking agents in intensive care.. Cisatracurium acts on cholinergic receptors, blocking neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine. Cisatracurium is an R-cis-R-cis isomer of [atracurium] and has approximately 3 times its neuromuscular blocking potency. Compared to atracurium, cisatracurium produces a lower degree of histamine release."}]